Binance Founder Zhao Changpeng Reveals Investment in Artificial Womb Company During Galaxy Interview
Zhao Changpeng Reveals Investment in Artificial Womb Company
Binance founder Zhao Changpeng revealed in a Galaxy interview that he has invested in an artificial womb company, which has completed mid-pregnancy experiments on mice.
He estimates that it may take 5 to 10 years before it can be applied to humans and expressed that his excitement for biotechnology exceeds that for AI and robotics.
Early investments in biotechnology are gaining attention, with assets in related regenerative medicine and assisted reproduction benefiting, while traditional fertility-related services are under pressure.
Source: Public Information
ABAB AI Insight
Zhao Changpeng is expanding his investment scope from crypto to AI and biotechnology through YZi Labs, having previously invested in data ownership and other life science projects, reflecting a tilt of his personal wealth towards long-term technology sectors.
On the capital path, resources are shifting from Web3 protocols to hard tech that addresses specific human health issues, motivated by the pursuit of innovations with more substantial impacts rather than mere financial instruments.
Similar cases can be seen where tech capital enters regenerative medicine and in vitro development research, such as companies like Colossal advancing artificial womb hardware; currently, they are in the early stages of transitioning from animal experiments to potential clinical applications.
Essentially, this represents a technological substitution: some functions of natural pregnancy may be supplemented or replaced by external systems, with the mechanism being breakthroughs in bioengineering that reduce physiological and social limitations on fertility.
ABAB News · Cognitive Law
Biological hard tech is more tangible and perceptible than AI
It will take a decade from mid-mouse experiments to human applications
Wealth ultimately flows towards solutions for fundamental human problems